Search

everythinglearnresearchcommunity

for

Search:↓

Erosive pustular dermatosis of the scalp is a rare condition that causes scarring hair loss, mainly in older women, and requires ongoing treatment.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

A 37-year-old man with hair loss and skin issues was successfully treated with oral antibiotics, highlighting the need for early treatment. Long-term care includes low-dose antibiotics and avoiding caps and wigs.

Different scalp conditions can lead to hair loss or tumors, with treatments varying from creams to surgery; early detection is crucial.

Aging affects hair density and skin health, and Behcet's disease, a complex condition with no specific test, involves sores and systemic issues, treated with various medications.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Folliculitis decalvans mainly affects middle-aged African American men and is treated with antibiotics.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

A dog with unusual skin lesions near its tail was successfully treated for a rare form of lupus.

The conclusion of the case is not provided in the summary.

HIV can cause unusual and severe skin problems that are hard to treat.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Erosive pustular dermatosis in elderly people may be linked to aging immune systems and skin damage.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Some drugs used to treat immune conditions may cause different types of hair loss.

Aging can lead to poorer scalp and hair health, including less hair and more scalp diseases, which should be managed to help older people feel better.

Old people's nails often have problems due to body changes, more diseases, and self-care difficulties, affecting their movement and hand use.

Skin fungal infections are more common in older adults due to factors like obesity, poor circulation, reduced mobility, and weakened immune defenses from certain medications.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.